ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: SA-PO683

Quasi-Frequent Hemodialysis Affects Hospitalization for Cardiovascular Disease and Cardiac Function in ESRD Patients with Severe Heart Failure

Session Information

Category: Dialysis

  • 604 Home and Frequent Dialysis

Authors

  • Banshodani, Masataka, Tsuchiya General Hospital, Hiroshima, Japan
  • Kawanishi, Hideki, Tsuchiya General Hospital, Hiroshima, Japan
  • Moriishi, Misaki, Tsuchiya General Hospital, Hiroshima, Japan
  • Shintaku, Sadanori, Tsuchiya General Hospital, Hiroshima, Japan
  • Tsuchiya, Shinichiro, Tsuchiya General Hospital, Hiroshima, Japan
Background

Previous reports indicated that frequent hemodialysis (FHD) maintained cardiac function. However, no reports have evaluated the impact of quasi-FHD (q-FHD) on hospitalization for cardiovascular diseases (CVDs) and cardiac function in end-stage renal disease (ESRD) patients with severe heart failure.

Methods

This is a retrospective observational study that evaluated hospitalizations for the period from 1 year before to 1 year after q-FHD initiation (≥4 times a week) and ejection fraction (EF) by using echocardiography in ESRD patients with severe heart failure (New York Heart Association Functional Classification III or IV) at a single center between 1995 and 2014.

Results

Of 1,955 hemodialysis (HD) patients, 60 (3.1%; 42 men; mean age, 65.4 years; mean dialysis vintage, 80.0 months) started q-FHD (mean, 4.3 ± 0.7 times a week) and 52 continuously received q-FHD (4.6 ± 0.8 times a week) 1 year later. The 1-year mortality rate after q-FHD initiation was 13.3%. The mean EF decreased from 61.8% at dialysis initiation to 50.6% at q-FHD initiation (P < 0.001) but did not change 1 year later (49.4%; P = 0.7). All-cause hospitalization rates (per person-year) were similar between before and after q-FHD initiation (1.79 [102 hospitalizations] vs 2.07 [115 hospitalizations]; P = 0.2). On the other hand, the emergency hospitalization rate for CVDs significantly decreased from 0.73 to 0.37 after q-FHD initiation (P = 0.002). However, the emergency hospitalization rates for infectious diseases, including vascular access-related infection, were similar between before and after q-FHD initiation (0.12 vs 0.16; P = 0.5).

Conclusion

The hospitalization rate for CVDs significantly decreased after the q-FHD initiation in the ESRD patients with severe heart failure. Moreover, q-FHD maintained cardiac function in these patients. Further multicenter studies are needed to evaluate these findings.